Nitrofurantoin (Macrobid) Use in Pregnancy
Nitrofurantoin can be used during the second and third trimesters of pregnancy as a first-line agent for urinary tract infections, but should be avoided in the first trimester unless no suitable alternatives exist, and is contraindicated at term (labor and delivery) and in nursing mothers with infants under one month of age.
FDA Classification and Contraindications
The FDA classifies nitrofurantoin as Pregnancy Category B, indicating animal studies show no fetal harm, though adequate human studies are lacking 1. However, the drug label carries specific contraindications:
- Absolutely contraindicated during labor and delivery due to risk of hemolytic anemia in the newborn 1
- Contraindicated in nursing mothers with infants under one month of age due to risk of hemolytic anemia 1
- Should only be used during pregnancy "if clearly needed" 1
Trimester-Specific Recommendations
First Trimester
Use only when no suitable alternatives are available. The evidence is mixed regarding teratogenic risk:
- A 2017 ACOG Committee Opinion states nitrofurantoin may be prescribed in the first trimester when no other suitable alternatives exist 2
- A 2015 meta-analysis found no increased risk in cohort studies (RR 1.01,95% CI 0.81-1.26) but a slight increase in case-control studies (OR 1.22,95% CI 1.02-1.45) 3
- A large Norwegian cohort study (180,120 pregnancies) found no increased risk of major malformations (2.3% vs 2.8%, OR 0.79) 4
- Some concern exists for hypoplastic left heart syndrome (OR 3.07,95% CI 1.59-5.93) 3, though this requires confirmation
Clinical approach: Prefer beta-lactam antibiotics (amoxicillin-clavulanate, cephalexin) as first-line in the first trimester. Reserve nitrofurantoin for cases with resistance or allergy to preferred agents.
Second and Third Trimesters
Nitrofurantoin is appropriate as a first-line agent during these trimesters 2. The drug demonstrates:
- High efficacy (88-93% clinical cure rates) 5
- Minimal resistance patterns
- Low collateral damage to gut microbiota 5, 6
At Term (Last 4 Weeks/Labor and Delivery)
Absolutely avoid nitrofurantoin. The FDA label explicitly contraindicates use during labor and delivery 1. One study found increased risk of neonatal jaundice when dispensed in the last 30 days before delivery (10.8% vs 8.1%, OR 1.31) 4.
Dosing Regimen for Pregnancy
When nitrofurantoin is indicated during pregnancy:
For acute uncomplicated cystitis:
- Nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5-7 days 5, 1
- Take with food to enhance absorption 1
Important: A 1-day regimen is significantly less effective than 7 days (75.7% vs 86.2% cure rate) and resulted in lower birth weight and gestational age 7. Always use the full 5-7 day course.
For asymptomatic bacteriuria in pregnancy:
- Use the standard 7-day regimen (100 mg twice daily) 7
- Do not use shortened courses
Key Clinical Caveats
Avoid if pyelonephritis suspected - nitrofurantoin achieves minimal tissue/serum concentrations and is ineffective for upper tract infections 5
Renal function - contraindicated if creatinine clearance <60 mL/min 1
G6PD deficiency - absolute contraindication due to hemolytic anemia risk 1
Monitor for pulmonary reactions - though rare, acute and chronic pulmonary reactions can occur 1
Drug interactions - avoid concurrent use with magnesium trisilicate antacids (reduces absorption) 1
Alternative Agents in Pregnancy
When nitrofurantoin is contraindicated or inappropriate:
- Beta-lactams (amoxicillin-clavulanate, cephalexin): Safe throughout pregnancy, 3-5 day courses
- Fosfomycin 3g single dose: May be used but has lower efficacy (80% microbiological cure vs 88% for nitrofurantoin) 5
The critical principle: untreated UTIs in pregnancy pose serious maternal and fetal risks (pyelonephritis, preterm labor, low birth weight), so appropriate antibiotic treatment should never be withheld 2.